同濟堂(600090.SH)擬2.7億元收購四川貝爾康60%股權
格隆匯12月10日丨同濟堂(600090.SH)公佈,公司擬以現金2.7億元的價格收購武漢清華卓健醫療投資管理有限公司(“清華卓健”)持有的四川貝爾康醫藥有限公司(“四川貝爾康”)60%股權。
四川貝爾康主營業務:批發:第二類精神藥品、生化藥品、中藥材、中藥飲片、生物制品(不含預防性生物製品)、化學原料藥、抗生素原料藥、中成藥、化學藥製劑、抗生素製劑、預包裝食品、乳製品(含嬰幼兒配方乳粉)、藥用輔料、醫療器械、化粧品、衞生用品、消毒用品、日用品、機械設備、電子產品、五金交電;會議服務;倉儲服務(不含危險品);網絡技術推廣服務(依法須經批准的項目,經相關部門批准後方可開展經營活動)。
未來發展方面,此次收購四川貝爾康股權是公司為了拓展公司在四川地區的業務經營,是公司“三線一帶”發展戰略的重要一步,增補了公司在四川地區業務的覆蓋。上述股權收購交易完成後,公司將持有四川貝爾康60%股權,四川貝爾康將納入公司的合併報表範圍。此次交易會促進公司的業務經營成果的發展,對公司的資產負債結構會產生一定調整。
四川貝爾康作為具備一定規模和區域競爭力的現代醫藥流通企業,擁有四川省全省範圍內的醫療機構市場和配送能力,該公司亦有意在業內持續發展並希望通過引入具有實力的股東進行重組,進一步發展壯大。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.